CDK2 and cancer: Generally speaking, the protein encoded by CCNA2 can activate CDK2, which may participate in the occurrence and progression of various tumors by affecting epithelial-mesenchymal transition (EMT), metastasis, and may enhance cancer invasion, recurrence, and chemotherapy resistance (21).